4//SEC Filing
Fiedorek Fred T. 4
Accession 0001209191-23-049999
CIK 0001840574other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 5:05 PM ET
Size
5.5 KB
Accession
0001209191-23-049999
Insider Transaction Report
Form 4
Fiedorek Fred T.
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2023-09-18+180,000→ 180,000 totalExercise: $12.71Exp: 2033-09-17→ Common Stock (180,000 underlying)
Footnotes (1)
- [F1]The option was granted on September 18, 2023. 25% of the shares underlying the option will vest on September 18, 2024, and the remainder are scheduled to vest in equal monthly installments thereafter until September 18, 2027.
Documents
Issuer
Verve Therapeutics, Inc.
CIK 0001840574
Entity typeother
Related Parties
1- filerCIK 0001657185
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 5:05 PM ET
- Size
- 5.5 KB